You are here
Clinical Trials: Nervous System Diseases
Each Clinical Trial will open in a new browser window or tab.
Condition: Chronic Stroke
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Intervention: Drug: GXNPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Conditions: Rotator Cuff Tears; Muscle Atrophy or Weakness; Tendon Rupture - Shoulder; Safety Issues
Intervention: Drug: E-CEL UVEC
Sponsors: Hospital for Special Surgery, New York; Orthopedic Research and Education Foundation
Not yet recruiting
Intervention: Drug: E-CEL UVEC
Sponsors: Hospital for Special Surgery, New York; Orthopedic Research and Education Foundation
Not yet recruiting
Condition: Acute Spinal Cord Injury
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 along with standard treatment
Sponsor: Pharmazz, Inc.
Recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 along with standard treatment
Sponsor: Pharmazz, Inc.
Recruiting
Conditions: Alzheimer Disease; Dementia
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Recruiting
Conditions: Cerebral Ischemia; Cerebral Infarction; Stroke, Acute
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Interventions: Drug: Normal Saline along with standard treatment; Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor: Pharmazz, Inc.
Not yet recruiting
Condition: Alzheimer Disease
Interventions: Biological: 100 million cells allogeneic hMSC; Biological: 200 million cells allogeneic hMSC
Sponsor: Bernard (Barry) Baumel
Not yet recruiting
Interventions: Biological: 100 million cells allogeneic hMSC; Biological: 200 million cells allogeneic hMSC
Sponsor: Bernard (Barry) Baumel
Not yet recruiting
Conditions: Intellectual Disability; Down Syndrome
Intervention: Behavioral: Self-monitoring shopping intervention
Sponsor: Columbia University
Recruiting
Intervention: Behavioral: Self-monitoring shopping intervention
Sponsor: Columbia University
Recruiting
Conditions: Stroke; Umbilical Cord Blood; Erythropoietin; Safety; Treatment Outcome
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Interventions: Drug: Umbilical cord blood infusion; Drug: Erythropoietin injection; Drug: Placebo umbilical cord blood infusion; Drug: Placebo erythropoietin injection; Procedure: Active rehabilitation
Sponsors: Bundang CHA Hospital; Korea Evaluation Institute of Industrial Technology
Recruiting
Condition: Spinal Cord Injuries
Interventions: Biological: Umbilical Cord Blood Mononuclear Cell; Drug: Lithium Carbonate; Other: Placebo; Other: Locomotor Training
Sponsors: StemCyte, Inc.; Amarex Clinical Research
Not yet recruiting
Interventions: Biological: Umbilical Cord Blood Mononuclear Cell; Drug: Lithium Carbonate; Other: Placebo; Other: Locomotor Training
Sponsors: StemCyte, Inc.; Amarex Clinical Research
Not yet recruiting
Condition: Traumatic Brain Injury
Interventions: Device: Light box therapy; Device: Negative Ion Generator
Sponsors: Portland VA Medical Center; Center for Neuroscience and Regenerative Medicine (CNRM)
Not yet recruiting
Interventions: Device: Light box therapy; Device: Negative Ion Generator
Sponsors: Portland VA Medical Center; Center for Neuroscience and Regenerative Medicine (CNRM)
Not yet recruiting
